EZH2 was up-regulated and expressed in many solid cancers, and YY1 can recruit EZH2 and suppress NFkB function in hepatitis B virus-dependent HCC (Chase and Cross, 2011). This evidence concerns the gene EZH2 and hepatocellular carcinoma.